Walleye Trading
NTLA icon

Walleye Trading’s Intellia Therapeutics NTLA Stock Holding History

Walleye Trading’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$236K Buy
+13,972
New +$196K ﹤0.01% 3048
2026
Q1 		– Sell
-11,663
Closed -$105K – 4518
2025
Q4 		$105K Buy
+11,663
New +$161K ﹤0.01% 3717
2025
Q3 		– Sell
-7,673
Closed -$94.5K – 4679
2025
Q2 		$72K Sell
7,673
-15,622
-67% -$128K ﹤0.01% 3713
2025
Q1 		$166K Buy
+23,295
New +$235K ﹤0.01% 3172
2024
Q3 		– Sell
-6,534
Closed -$146K – 4439
2024
Q2 		$146K Buy
+6,534
New +$156K ﹤0.01% 3226
2024
Q1 		– Sell
-12,198
Closed -$339K – 5148
2023
Q4 		$372K Sell
12,198
-8,942
-42% -$257K ﹤0.01% 3323
2023
Q3 		$668K Buy
+21,140
New +$820K ﹤0.01% 2708
2021
Q4 		– Sell
-19,391
Closed -$2.43M – 5692
2021
Q3 		$2.6M Sell
19,391
-12,349
-39% -$1.87M 0.01% 1391
2021
Q2 		$5.14M Buy
31,740
+26,132
+466% +$2.03M 0.02% 783
2021
Q1 		$450K Buy
+5,608
New +$376K ﹤0.01% 2762
2020
Q1 		– Sell
-6,138
Closed -$90K – 4368
2019
Q4 		$90K Buy
+6,138
New +$85.4K ﹤0.01% 3604
2019
Q1 		– Sell
-16,246
Closed -$242K – 4587
2018
Q4 		$222K Buy
+16,246
New +$302K ﹤0.01% 3295
2018
Q2 		– Sell
-651
Closed -$15.8K – 4793
2018
Q1 		$14K Sell
651
-1,249
-66% -$30.7K ﹤0.01% 4332
2017
Q4 		$37K Buy
+1,900
New +$43.9K ﹤0.01% 4089

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return

Walleye Trading's NTLA Position: Q2 2026 in Review

Walleye Trading opened a new position in Intellia Therapeutics (NTLA) in Q2 2026: 13,972 shares worth $236K. The stake represents ﹤0.01% of the portfolio and ranks #3048 among its holdings. This is a return to the name: Walleye Trading previously reported a position in NTLA as recently as Q4 2025.

Walleye Trading first reported a position in NTLA in Q4 2017 and has held it in 14 quarters since. The position peaked at $5.14M in Q2 2021. 328 funds tracked by Wall St. Rank hold NTLA as of Q2 2026.

  • Walleye Trading held 13,972 shares of Intellia Therapeutics worth $236K as of Q2 2026.
  • Intellia Therapeutics was a new Walleye Trading position in Q2 2026.
  • Intellia Therapeutics made up ﹤0.01% of Walleye Trading's portfolio in Q2 2026, its #3048 holding.
  • Walleye Trading first reported a position in Intellia Therapeutics in Q4 2017 and has held it in 14 quarters since.
  • Walleye Trading's Intellia Therapeutics position peaked at $5.14M in Q2 2021.
  • 328 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.